SANTA CLARA, Calif.--(BUSINESS WIRE)--Reviva Pharmaceuticals, Inc., (Reviva), a privately held drug discovery and development company, announced today that it has appointed life sciences industry experts, Brian G. Atwood, Sarvajna Dwivedi and Peder K. Jensen to its Board of Directors. “We are extremely pleased to welcome Mr. Atwood, Dr. Jensen and Dr. Dwivedi to the Board,” said Laxminarayan Bhat, Founder, President and Chief Executive Officer of Reviva.
Help employers find you! Check out all the jobs and post your resume.
